ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative)	6 Months Ended
	Jun. 30, 2019 USD ($) ft² $ / shares	Dec. 31, 2018 USD ($) $ / shares	Jun. 30, 2018 USD ($)	Dec. 31, 2017 USD ($)	Nov. 10, 2017 shares
State of Incorporation	Nevada
Date of Incorporation	May 15, 2014
Common stock par value | $ / shares	$ 0.001	$ 0.001
Accumulated deficit	$ (51,944,775)	$ (29,269,000)
Cash	7,644,610	$ 500,962	$ 161,051	$ 108,249
Working capital deficit	(6,800,000)
Net cash from acquisition of CHI	$ 7,300,000
Oxnard, CA [Member]
Area of cGMP manufacturing plant | ft²	25,000
Oak Therapeutics [Member]
Shares received | shares					269,000
Ownership percentage					63.00%